Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Apr-24 7:02 PM View:  | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Option Exercise | 20,000 | $2.48 | $49,600.00 | 100% 0 to 20.0K | |
| 15-Apr-24 7:02 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Planned Option Sale | 20,000 | $25.07 | $501,478.00 | (100%) 20.0K to 0 | |
| 19-Apr-21 7:53 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Grant | 66,000 | -- | -- | 95% 69.55K to 135.55K | |
| 19-Apr-21 7:53 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 16-Apr-21 | Disposition | 135,547 | $38.00 | $5,150,790.00 | (100%) 135.55K to 0 | |
| 19-Apr-21 7:53 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 31-Mar-21 | Gift | 8,085 | -- | -- | (10%) 77.63K to 69.55K | |
| 02-Mar-21 12:08 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-21 | Payment of Exercise | 1,158 | $22.23 | $25,742.30 | (1%) 78.79K to 77.63K | (71%) |
| 26-Feb-21 2:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-21 | Payment of Exercise | 1,653 | $23.08 | $38,151.20 | (2%) 80.44K to 78.79K | (65%) |
| 26-Feb-21 2:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Feb-21 | Payment of Exercise | 5,091 | $25.71 | $130,890.00 | (6%) 85.53K to 80.44K | (48%) |
| 15-Dec-20 12:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Dec-20 | Payment of Exercise | 11,583 | $16.14 | $186,950.00 | (12%) 97.12K to 85.53K | (135%) |
| 15-Dec-20 12:00 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Dec-20 | Option Exercise | 22,000 | -- | -- | 29% 75.12K to 97.12K | |
| 13-Nov-20 12:25 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-20 | Payment of Exercise | 11,039 | $18.00 | $198,702.00 | (13%) 86.16K to 75.12K | (111%) |
| 13-Nov-20 12:25 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 11-Nov-20 | Option Exercise | 22,000 | -- | -- | 34% 64.16K to 86.16K | |
| 24-Aug-20 1:46 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Aug-20 | Payment of Exercise | 827 | $4.69 | $3,878.63 | (1%) 64.98K to 64.16K | (709%) |
| 23-Mar-20 12:11 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Mar-20 | Payment of Exercise | 827 | $2.30 | $1,902.10 | (1%) 65.81K to 64.98K | (1547%) |
| 26-Feb-20 8:22 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-20 | Payment of Exercise | 1,281 | $4.83 | $6,187.23 | (2%) 67.09K to 65.81K | (684%) |
| 26-Feb-20 8:22 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-20 | Payment of Exercise | 1,862 | $4.87 | $9,067.94 | (3%) 68.95K to 67.09K | (678%) |
| 26-Feb-20 8:22 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Feb-20 | Grant | 30,000 | -- | -- | 77% 38.95K to 68.95K | |
| 06-Feb-20 6:51 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-20 | Payment of Exercise | 5,345 | $5.13 | $27,419.90 | (12%) 44.3K to 38.95K | (639%) |
| 04-Sep-19 1:12 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-19 | Payment of Exercise | 496 | $5.43 | $2,693.28 | (1%) 44.79K to 44.3K | (598%) |
| 22-Aug-19 6:50 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Aug-19 | Grant | 5,000 | -- | -- | 13% 39.79K to 44.79K | |
| 27-Feb-19 7:58 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-19 | Payment of Exercise | 1,177 | $11.95 | $14,065.10 | (3%) 40.97K to 39.79K | (217%) |
| 27-Feb-19 7:58 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 25-Feb-19 | Grant | 10,000 | -- | -- | 32% 30.97K to 40.97K | |
| 07-Feb-19 5:21 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-19 | Payment of Exercise | 3,196 | $11.43 | $36,530.30 | (9%) 34.17K to 30.97K | (231%) |
| 02-Oct-18 6:43 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Sep-18 | Grant | 3,844 | -- | -- | 12% 32.23K to 36.07K | |
| 02-Oct-18 6:43 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 28-Sep-18 | Payment of Exercise | 1,906 | $13.92 | $26,531.50 | (5%) 36.07K to 34.17K | (172%) |
| 05-Sep-18 11:22 AM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-18 | Payment of Exercise | 496 | $14.00 | $6,944.00 | (2%) 32.73K to 32.23K | (171%) |
| 26-Jun-18 8:16 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Jun-18 | Payment of Exercise | 1,240 | $17.38 | $21,551.20 | (4%) 33.97K to 32.73K | (118%) |
| 22-Mar-18 2:50 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Mar-18 | Payment of Exercise | 827 | $16.26 | $13,447.00 | (2%) 34.79K to 33.97K | (133%) |
| 28-Feb-18 7:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 26-Feb-18 | Grant | 7,000 | -- | -- | 25% 27.79K to 34.79K | |
| 07-Feb-18 2:05 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 05-Feb-18 | Payment of Exercise | 1,048 | $18.42 | $19,304.20 | (4%) 24.78K to 23.73K | (106%) |
| 06-Sep-17 7:11 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 01-Sep-17 | Payment of Exercise | 376 | $34.34 | $12,911.80 | (1%) 25.16K to 24.78K | (10%) |
| 28-Feb-18 7:18 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 23-Jun-17 | Payment of Exercise | 940 | $31.24 | $29,365.60 | (3%) 28.73K to 27.79K | (21%) |
| 26-Apr-17 4:36 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 24-Apr-17 | Grant | 1,250 | -- | -- | 5% 23.91K to 25.16K | |
| 22-Mar-17 5:45 PM View: | Five Prime Therapeutics, Inc. (FPRX) | 20-Mar-17 | Grant | 3,750 | -- | -- | 19% 20.16K to 23.91K |